Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Clinical trial NCT06643130 · RECRUITING
Trial details
- NCT number
- NCT06643130
- Sponsor
- JW Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-02
- Primary completion
- 2026-04-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.